Maria Beatriz Herrera Sanchez

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Fresenius Medical Care Deutschland Gmbh, Unicyte Ev Ag. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Beatriz Herrera Sanchez. Retrieved from https://idiyas.com/inventor/maria-beatriz-herrera-sanchez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 38(Granted Patents)

Company Filing History:

6 out of 885

Fresenius Medical Care Deutschland Gmbh

Years Active: 2015-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12239671 - Extracellular vesicles derived from human liver stem cells (HLSCs) (2025-03-04),

2. 10456425 - Conditioned medium of liver progenitor cells (2019-10-29),

3. 10357519 - Conditioned medium of liver progenitor cells (2019-07-23),

4. 10105395 - Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease (2018-10-23),

5. 9717760 - Microvesicles (MVS) derived from adult stem cells for use in the therapeutic treatment of a tumor disease (2017-08-01),

6. 9334479 - Liver progenitor cells (2016-05-10),

7. 9034335 - Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease (2015-05-19),

Title: Maria Beatriz Herrera Sanchez: Innovator in Regenerative Medicine

Introduction

Maria Beatriz Herrera Sanchez is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of regenerative medicine, holding a total of 7 patents. Her work focuses on innovative therapeutic applications that address cellular senescence and organ regeneration.

Latest Patents

One of her latest patents involves the preparation of extracellular vesicles derived from human liver stem cells (HLSCs). This preparation is capable of reducing the senescence of a population of senescent cells, as measured in a SA-β-galactosidase-based cellular senescence assay. The therapeutic applications of this invention include the treatment of diseases related to aging and cellular senescence, such as atherosclerosis and type 2 diabetes mellitus. Another notable patent pertains to the conditioned medium of liver progenitor cells, which has been found to exert a tissue regenerating effect. This cell-free conditioned medium is particularly useful in treating liver injuries and organ failures.

Career Highlights

Maria has worked with notable companies in the medical field, including Fresenius Medical Care Deutschland GmbH and Unicyte AG. Her experience in these organizations has contributed to her expertise in regenerative medicine and cellular therapies.

Collaborations

Throughout her career, Maria has collaborated with esteemed colleagues such as Giovanni Camussi and Valentina Fonsato. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Maria Beatriz Herrera Sanchez is a trailblazer in regenerative medicine, with a focus on innovative solutions for aging-related conditions. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.